Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy

MLA

Mu-Gen Dai, et al. “Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy.” Clinical Medicine Insights: Oncology, vol. 17, June 2023. EBSCOhost, https://doi.org/10.1177/11795549231180351.

APA

Mu-Gen Dai, Si-Yu Liu, Wen-Feng Lu, Lei Liang, & Bin Ye. (2023). Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy. Clinical Medicine Insights: Oncology, 17. https://doi.org/10.1177/11795549231180351

Chicago

Mu-Gen Dai, Si-Yu Liu, Wen-Feng Lu, Lei Liang, and Bin Ye. 2023. “Survival Benefits From Adjuvant Lenvatinib for Patients With Hepatocellular Carcinoma and Microvascular Invasion After Curative Hepatectomy.” Clinical Medicine Insights: Oncology 17 (June). doi:10.1177/11795549231180351.